Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: A meta-analysis

Endocrine

Volumn 46, Issue 1, 2014, Pages 52-59

  Trimboli, Pierpaolo ^a   Treglia, Giorgio ^b   Guidobaldi, Leo ^a   Saggiorato, Enrico ^c   Nigri, Giuseppe ^d   Crescenzi, Anna ^a   Romanelli, Francesco ^e   Orlandi, Fabio ^c   Valabrega, Stefano ^d   Sadeghi, Ramin ^f   Giovanella, Luca ^b  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^c Department of Clinical and Biological Sciences   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age; Cytology; Gender; Thy 3; Thyroid

Indexed keywords

AGE; ARTICLE; CANCER RISK; CLINICAL FEATURE; CYTOLOGY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; INDETERMINATE THYROID NODULE; META ANALYSIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; THYROID CANCER; THYROID NODULE; TUMOR VOLUME;

FEMALE; HUMANS; MALE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; THYROID NEOPLASMS; THYROID NODULE;

EID: 84898793911     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0057-1     Document Type: Article

References (50)

1. H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedüs, P. Vitti, AACE/AME/ETA task force on thyroid nodules: American association of clinical endocrinologists, associ-azione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 16, 1-43 (2010)
2. Guidelines for the management of thyroid cancer (second edition) Royal College of Physicians of London. The Lavenham Press, Suffolk 2007
3. Z.W. Baloch, M.J. Sack, G.H. Yu, V.A. Livolsi, P.K. Gupta, Fine-needle aspiration of thyroid: an institutional experience. Thyroid. 8, 565-569 (1998)
4. E.S. Cibas, S.Z. Ali, The bethesda system for reporting thyroid cytopathology. Thyroid. 19, 1159-1165 (2009)
5. A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco, R. Rossetto, N. Palestini, E. Ghigo, M. Papotti, G. Bussolati, M.P. Martegani, F. Pantellini, A. Carpi, M.R. Giovagnoli, S. Monti, V. Toscano, S. Sciacchitano, G.M. Pennelli, C. Mian, M.R. Pelizzo, M. Rugge, G. Troncone, L. Palombini, G. Chiappetta, G. Botti, A. Vecchione, R. Bellocco, Italian Thyroid Cancer Study Group (ITCSG): galectin-3-expression analysis in the surgicalselection of follicularthyroidnoduleswith indeterminate fine-needle aspiration cytology: a prospectivemulticentrestudy. Lancet. Oncol. 9, 543-549 (2008)
6. P. Trimboli, E. Condorelli, A. Catania, S. Sorrenti, Clinical and ultrasound parameters in the approach to thyroid nodules cyto-logically classified as indeterminate neoplasm. Diagn. Cytopa-thol. 37, 783-785 (2009)
7. T. Rago, G. Di Coscio, C. Ugolini, M. Scutari, F. Basolo, F. Latrofa, R. Romani, P. Berti, L. Grasso, L.E. Braverman, A. Pinchera, P. Vitti, Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin. Endocrinol. (Oxf) 67, 363-369 (2007)
8. N.L. Davis, M. Gordon, E. Germann, R.E. Robins, G.I. McGregor, Clinical parameters predictive of malignancy of thyroid follicular neoplasms. Am. J. Surg. 161, 567-569 (1991)
9. H. Chen, T.L. Nicol, M.A. Zeiger, W.C. Dooley, P.W. Ladenson, D.S. Cooper, M. Ringel, S. Parkerson, M. Allo, R. Udelsman, Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann. Surg. 227, 542-546 (1998)
10. R.M. Tuttle, H. Lemar, H.B. Burch, Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 8, 377-383 (1998)
11. C.R. McHenry, S.R. Thomas, S.J. Slusarczyk, A. Khiyami, Fol-licular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery. 126, 798-804 (1999)
12. W. Raber, K. Kaserer, B. Niederle, H. Vierhapper, Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 10, 709-712 (2000)
13. Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41-44 (2002)
14. E.S. Kim, I.S. Nam-Goong, G. Gong, S.J. Hong, W.B. Kim, Y.K. Shong, Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm". Korean. J. Intern. Med. 18, 94-97 (2003)
15. T. Giorgadze, E.D. Rossi, G. Fadda, P.K. Gupta, V.A. Livolsi, Z. Baloch, Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn. Cytopathol. 31, 307-312 (2004)
16. J. Smith, R.E. Cheifetz, N. Schneidereit, K. Berean, T. Thomson, Can cytology accurately predict benign follicular nodules? Am. J. Surg. 189, 592-595 (2005)
17. R.T. Pu, J. Yang, P.G. Wasserman, T. Bhuiya, K.A. Griffith, C.W. Michael, Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn. Cytopathol. 34, 330-334 (2006)
18. M. Sahin, A. Gursoy, N.B. Tutuncu, D.N. Guvener, Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin. Endocrinol. (Oxf) 65, 514-518 (2006)
19. T. Rago, G. Di Coscio, F. Basolo, M. Scutari, R. Elisei, P. Berti, P. Miccoli, R. Romani, P. Faviana, A. Pinchera, P. Vitti, Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hürthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin. Endocrinol. (Oxf) 66, 13-20 (2007)
20. J.C. Paramo, T. Mesko, Age, tumor size, and in-office ultraso-nography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr. Pract. 14, 447-451 (2008)
21. P. Trimboli, S. Ulisse, M. D'Alò, F. Solari, A. Fumarola, M. Ruggieri, E. De Antoni, A. Catania, S. Sorrenti, F. Nardi, M. D'Armiento, Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predictingmalignancy in follicu-larthyroidneoplasms. Clin. Endocrinol. (Oxf) 69, 342-344 (2008)
22. N.E. Gulcelik, M.A. Gulcelik, B. Kuru, Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch. Otolaryngol. Head Neck Surg. 134, 1312-1315 (2008)
23. R. Mihai, A.J. Parker, D. Roskell, G.P. Sadler, One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid. 19, 33-37 (2009)
24. S. Sorrenti, P. Trimboli, A. Catania, S. Ulisse, E. De Antoni, M. D'Armiento, Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm. Thyroid. 19, 355-360 (2009)
25. C.C. Lubitz, W.C. Faquin, J. Yang, M. Mekel, R.D. Gaz, S. Parangi, G.W. Randolph, R.A. Hodin, A.E. Stephen, Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 20, 25-31 (2010)
26. R. Asari, B.E. Niederle, C. Scheuba, P. Riss, O. Koperek, K. Kaserer, B. Niederle, Indeterminate thyroid nodules: a challenge for the surgical strategy. Surgery. 148, 516-525 (2010)
27. R.T. Schlinkert, J.A. van Heerden, J.R. Goellner, H. Gharib, S.L. Smith, R.F. Rosales, A.L. Weaver, Factors that predict malignant thyroid lesion when fine needle aspiration is suspicious for fol-licular neoplasm. Mayo. Clinics. Proc. 72, 913-916 (1997)
28. Z.W. Baloch, S. Fleisher, V.A. LiVolsi, P.K. Gupta, Diagnosis of follicular neoplasm: a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26, 41-44 (2001)
29. N.D. Banks, J. Kowalski, H.L. Tsai, H. Somervell, R. Tufano, A.P. Dackiw, M.R. Marohn, D.P. Clark, C.B. Umbricht, M.A. Zeiger, A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid. 18, 933-941 (2008)
30. M.L. Carcangiu, S. Bianchi, D. Savino, I.M. Voynick, J. Rosai, Follicular Hurthle cell tumors of the thyroid. Cancer. 68, 1944-1953 (1991)
31. G. Bahar, D. Braslavsky, T. Shpitzer, R. Feinmesser, S. Avidan, A. Popovtzer, S. Karl, The cytological and clinical value of the thyroid follicular lesion. Am. J. Otolaryngol. 24, 217-220 (2003)
32. T. Rago, M. Scutari, F. Santini, V. Loiacono, P. Piaggi, G. Di Coscio, F. Basolo, P. Berti, A. Pinchera, P. Vitti, Real-time elastosonography: usefultool for refining the presurgicaldiagnosis in thyroid nodules withindeterminate or nondiagnosticcytology. J. Clin. Endocrinol. Metab. 95, 5274-5280 (2010)
33. P.V. Lippolis, S. Tognini, G. Materazzi, A. Polini, R. Mancini, C.E. Ambrosini, A. Dardano, F. Basolo, M. Seccia, P. Miccoli, F. Monzani, Is elastography actually useful in the presurgicalse-lection of thyroid nodules withindeterminatecytology? J. Clin. Endocrinol. Metab. 96, E1826-E1830 (2011)
34. U. Unlütürk, M.F. Erdogan, O. Demir, S. Güllü, N. Başkal, Ultrasound-elastography is not superior to gray-scale ultrasound in predicting malignancy in thyroid nodules. Thyroid. 22, 1031-1038 (2012)
35. D. Vriens, J.H. de Wilt, G.J. van der Wilt, R.T. Netea-Maier, W.J. Oyen, L.F. de Geus-Oei, The role of [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 117, 4582-4594 (2011)
36. D. Deandreis, A. Al Ghuzlan, A. Auperin, P. Vielh, B. Caillou, L. Chami, J. Lumbroso, J.P. Travagli, D. Hartl, E. Baudin, M. Schlumberger, S. Leboulleux, Is (18)F-fluorodeoxyglucose-PET/ CT useful for the presurgical characterization ofthyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 22, 165-172 (2012)
37. G. Treglia, B. Muoio, L. Giovanella, M. Salvatori, The role of positron emissiontomography and positron emission tomography/ computed tomography in thyroid tumours: an overview. Eur. Arch. Otorhinolaryngol. 270, 1783-1787 (2013)
38. E. Saggiorato, T. Angusti, R. Rosas, M. Martinese, M. Finessi, F. Arecco, E. Trevisiol, N. Bergero, B. Puligheddu, M. Volante, V. Podio, M. Papotti, F. Orlandi, 99 mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J. Nucl. Med. 50, 1785-1793 (2009)
39. L.M. Hurtado-López, S. Arellano-Montaño, E.M. Torres-Acosta, F.R. Zaldivar-Ramirez, R.M. Duarte-Torres, P. Alonso-De-Ruiz, I. Martínez-Duncker, C. Martínez-Duncker, Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur. J. Nucl. Med. Mol. Imaging. 31, 1273-1279 (2004)
40. R. Sharma, A. Mondal, L.R. Shankar, M. Sahoo, P. Bhatnagar, K. Sawroop, M.K. Chopra, R. Kashyap, Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute tc-99 m MIBI scans. Clin. Nucl. Med. 29, 534-537 (2004)
41. G. Treglia, C. Caldarella, E. Saggiorato, L. Ceriani, F. Orlandi, M. Salvatori, L. Giovanella, Diagnostic performance of (99 m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 44, 70-78 (2013)
42. Y.E. Nikiforov, L. Yip, M.N. Nikiforova, New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin. Cancer. Res. 19, 2283-2288 (2013)
43. G. Salvatore, R. Giannini, P. Faviana, A. Caleo, I. Migliaccio, J.A. Fagin, Y.E. Nikiforov, G. Troncone, L. Palombini, F. Ba-solo, M. Santoro, Analysis of BRAF point mutation and RET/ PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 89, 5175-5180 (2004)
44. M.N. Nikiforova, G.C. Tseng, D. Steward, D. Diorio, Y.E. Nik-iforov, MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 93, 1600-1608 (2008)
45. E. Saggiorato, R. De Pompa, M. Volante, S. Cappia, F. Arecco, A.P. Dei Tos, F. Orlandi, M. Papotti, Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr. Relat. Cancer 12, 305-317 (2005)
46. Y.Y. Liu, H. Morreau, J. Kievit, J.A. Romijn, N. Carrasco, J.W. Smit, Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, per-oxisome proliferator-activated receptor-{gamma}, and sodium/ iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Eur. J. Endocrinol. 158, 375-384 (2008)
47. K.T. Park, S.H. Ahn, J.H. Mo, Y.J. Park, J. Park, S.I. Choi, S.Y. Park, Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head. Neck. 33, 160-165 (2011)
48. D.G. Na, J.H. Kim, J.Y. Sung, J.H. Baek, K.C. Jung, H. Lee, H. Yoo, Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the bethesda system for reporting thyroid cytopathology. Thyroid. 22, 468-475 (2012)
49. N. Nasrollah, P. Trimboli, L. Guidobaldi, D.D. Cicciarella Modica, C. Ventura, G. Ramacciato, S. Taccogna, F. Romanelli, S. Valabrega, A. Crescenzi, Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine. 43, 659-665 (2013)
50. American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19, 1167-1214 (2009)